These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


360 related items for PubMed ID: 7534015

  • 1. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 2. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 3. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 01; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 4. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG.
    Cancer Res; 1994 Mar 15; 54(6):1397-401. PubMed ID: 8137236
    [Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S.
    Oncogene; 1997 Aug 14; 15(7):871-4. PubMed ID: 9266974
    [Abstract] [Full Text] [Related]

  • 6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 7. Histopathology, classification, and grading of gliomas.
    Kleihues P, Soylemezoglu F, Schäuble B, Scheithauer BW, Burger PC.
    Glia; 1995 Nov 01; 15(3):211-21. PubMed ID: 8586458
    [Abstract] [Full Text] [Related]

  • 8. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 01; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

  • 9. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas.
    Leenstra S, Troost D, Westerveld A, Bosch DA, Hulsebos TJ.
    Cancer Res; 1992 Mar 15; 52(6):1568-72. PubMed ID: 1311634
    [Abstract] [Full Text] [Related]

  • 10. Genetic alterations associated with the evolution and progression of astrocytic brain tumours.
    Ohgaki H, Schäuble B, zur Hausen A, von Ammon K, Kleihues P.
    Virchows Arch; 1995 Mar 15; 427(2):113-8. PubMed ID: 7582239
    [Abstract] [Full Text] [Related]

  • 11. Gliomas.
    Collins VP.
    Cancer Surv; 1998 Mar 15; 32():37-51. PubMed ID: 10489622
    [Abstract] [Full Text] [Related]

  • 12. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep 15; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 Aug 01; 52(15):4277-9. PubMed ID: 1353411
    [Abstract] [Full Text] [Related]

  • 14. Somatic mutations of PTEN in glioblastoma multiforme.
    Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R.
    Cancer Res; 1997 Oct 01; 57(19):4183-6. PubMed ID: 9331071
    [Abstract] [Full Text] [Related]

  • 15. Loss of P16INK4 expression is frequent in high grade gliomas.
    Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK, Su Huang HJ.
    Cancer Res; 1995 May 01; 55(9):1941-5. PubMed ID: 7728764
    [Abstract] [Full Text] [Related]

  • 16. Molecular pathways in the formation of gliomas.
    von Deimling A, Louis DN, Wiestler OD.
    Glia; 1995 Nov 01; 15(3):328-38. PubMed ID: 8586467
    [Abstract] [Full Text] [Related]

  • 17. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW, Broholm H, Laursen H.
    Ugeskr Laeger; 2006 Oct 30; 168(44):3813-6. PubMed ID: 17118240
    [Abstract] [Full Text] [Related]

  • 18. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G.
    Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190
    [Abstract] [Full Text] [Related]

  • 19. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct 01; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 20. Alterations of the TP53 gene in human gliomas.
    Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH.
    Cancer Res; 1994 Mar 01; 54(5):1324-30. PubMed ID: 8118823
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.